Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X about a recent paper by Markus Diefenhardt et al. published in JAMA Network Open.
“German Rectal Cancer Study Group informs prognostic significance of ypN+ after nCRT
ypN+ (ypN2) associated with:
- High DM
- High Locoregional recurrence
- Low OS
Trials needed to explore post-op intensification? How to integrate with other biomarkers (eg ctDNA)?”
“Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer”
Authors: Markus Diefenhardt, Daniel Martin, Ralf-Dieter Hofheinz, Michael Ghadimi, Emmanouil Fokas, Claus Rödel, Maximilian Fleischmann.
More posts featuring Krishan Jethwa.
